128 related articles for article (PubMed ID: 3001193)
1. Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement.
Middeldorp JM; Jongsma J; The TH
J Infect Dis; 1986 Jan; 153(1):48-55. PubMed ID: 3001193
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated cytolytic activity associated with cytomegalovirus complement-fixing IgM antibody.
Booth JC; Mohammed HS
J Med Virol; 1988 Mar; 24(3):351-9. PubMed ID: 2835430
[TBL] [Abstract][Full Text] [Related]
3. Cytolytic IgM antibody to cytomegalovirus in primary cytomegalovirus infection in humans.
Betts RF; Schmidt SG
J Infect Dis; 1981 Jun; 143(6):821-6. PubMed ID: 6265566
[TBL] [Abstract][Full Text] [Related]
4. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.
Rasmussen L; Kelsall D; Nelson R; Carney W; Hirsch M; Winston D; Preiksaitis J; Merigan TC
J Infect Dis; 1982 Feb; 145(2):191-9. PubMed ID: 6274969
[TBL] [Abstract][Full Text] [Related]
5. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.
Van der Giessen M; van den Berg AP; van der Bij W; Postma S; van Son WJ; The TH
Clin Exp Immunol; 1990 Apr; 80(1):56-61. PubMed ID: 2157567
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections.
O'Neill HJ; Shirodaria PV; Connolly JH; Simpson DI; McGeown MG
J Med Virol; 1988 Apr; 24(4):461-70. PubMed ID: 2835436
[TBL] [Abstract][Full Text] [Related]
7. Studies of cytomegalovirus infection in renal allograft recipients. II. Serological response to various viral antigens.
Gadler H; Sundqvist V; Tillegård A; Wahren B
Scand J Infect Dis; 1982; 14(2):89-94. PubMed ID: 6285452
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.
Roenhorst HW; Middeldorp JM; Beelen JM; Schirm J; Tegzess AM; The TH
Clin Exp Immunol; 1985 Mar; 59(3):709-15. PubMed ID: 2985307
[TBL] [Abstract][Full Text] [Related]
9. Murine Cytomegalovirus-induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection.
Saunders U; Li M; Boddeda SR; Maher S; Ghere J; Kaptsan I; Dhital R; Velazquez V; Guo L; Chen B; Zeng Q; Schoeb TR; Cianciolo R; Shimamura M
Transplantation; 2021 Aug; 105(8):1718-1729. PubMed ID: 33214535
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.
Kangro HO
Br J Exp Pathol; 1980 Oct; 61(5):512-20. PubMed ID: 6255978
[TBL] [Abstract][Full Text] [Related]
11. Indirect immunofluorescence test for detection of IgM antibodies to cytomegalovirus.
Hekker AC; Brand-Saathof B; Vis J; Meijers RC
J Infect Dis; 1979 Oct; 140(4):596-600. PubMed ID: 229176
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera.
Middeldorp JM; Jongsma J; The TH
J Virol; 1985 Apr; 54(1):240-4. PubMed ID: 2983117
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection.
van Zanten J; van der Giessen M; van der Voort LH; van Son WJ; van der Bij W; The TH
Clin Exp Immunol; 1991 Jan; 83(1):102-7. PubMed ID: 1846328
[TBL] [Abstract][Full Text] [Related]
14. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
Eichler C; Kaden J; May G
Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
[TBL] [Abstract][Full Text] [Related]
15. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic of immune response in primary cytomegalovirus infection and after reactivation of cytomegalovirus in patients with organ allotransplantation].
Pustowoit B; Herrmann F; Makarova NE; Kushch AA
Vopr Virusol; 2001; 46(2):24-9. PubMed ID: 11392966
[TBL] [Abstract][Full Text] [Related]
17. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
[TBL] [Abstract][Full Text] [Related]
19. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
20. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
